tiprankstipranks
Trending News
More News >
Mabion SA (DE:272)
FRANKFURT:272

Compare Mabion SA (272) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Mabion SA
€1.85
€34.00M
-3.23
-16.94%
Ryvu Therapeutics SA
zł27.65
zł499.40M
-6.19
12.03%
Scope Fluidics SA
zł143.40
zł446.73M
-10.13
-23.70%
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
zł3.68
zł278.84M
-10.03
-19.65%
Captor Therapeutics SA
zł42.20
zł417.62M
-4.87
81.20%
OncoArendi Therapeutics SA
zł6.08
zł125.27M
-7.21
-26.75%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:272
Mabion SA
2.01
-0.39
-16.25%
PL:RVU
Ryvu Therapeutics SA
21.60
-0.40
-1.82%
PL:SCP
Scope Fluidics SA
141.00
-44.60
-24.03%
PL:SVE
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
3.68
-0.98
-21.03%
PL:CTX
Captor Therapeutics SA
75.20
35.50
89.42%
PL:MOC
OncoArendi Therapeutics SA
6.08
-2.42
-28.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts